The Efficacy of Qianglidingxuan Tablets in the Treatment of Hypertension
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 269 participants.
Also called NCT05521282
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 269 participants
- Sponsor
- Registry
-
NCT05521282
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT05521282. Randomized; single masking; primary purpose treatment. Start 2021-03-09 (actual); primary completion 2022-06-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Efficacy of Qianglidingxuan Tablets in the Treatment of Hypertension
- Condition
- Hypertension
- Condition
- Medicine, Chinese Traditional
- Intervention (Drug)
- Treatment group
- Lead sponsor
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- Collaborator
- The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
- Collaborator
- The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
- Collaborator
- Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine
- Collaborator
- Affiliated Hospital of Changchun University of Chinese Medicine
Record details
- Record id
cardio:ct-nct05521282- Content hash
d9df5f9e4a1203ceb5bb78306031692ffbfa0f2a6ba28a3fe5d44d5d5327e23a